Beyond CDK4/6: Proximity-Based Degraders Redefine Cancer Cell-Cycle Targeting
The assumption that blocking a kinase's enzymatic activity is the best way to disable a cancer driver is being…
The assumption that blocking a kinase's enzymatic activity is the best way to disable a cancer driver is being…
One of the most persistent obstacles to deploying AI in clinical oncology isn't accuracy — it's knowing when the AI…
For four decades, American overdose deaths climbed with such mechanical consistency that researchers modeled them as a…
Where people die matters profoundly for their final quality of life — and mounting evidence links dying in one's…
Vaccination status has emerged as the single most powerful predictor of severe mpox outcomes in the United States — a…
For the millions of breast cancer survivors living under the shadow of potential relapse, the difference between…
For the roughly 6–7 million people living with Chagas disease, treatment options remain limited partly because the…
For older adults navigating an ever-shifting COVID-19 landscape, real-world evidence on antiviral effectiveness…
For the millions living with Parkinson's disease, deep brain stimulation has transformed motor function — but its…
When the primary gateway to reproductive health information is an algorithm-driven feed, the downstream consequences…
For the millions living with Parkinson's disease, cognitive decline is one of the most feared complications — and…
Tuberculosis remains one of medicine's most urgent unsolved problems — not because science lacks tools, but because…
Understanding why schizophrenia produces such a heterogeneous constellation of symptoms — from hallucinations to…
For people living with drug-resistant epilepsy, temperature sensitivity is more than an anecdotal complaint — it may…
Brief clinical encounters hold untapped potential for preventing chronic disease — but only if the healthcare…
Among people with HIV (PWH) on antiretroviral therapy (ART), GLP-1 receptor agonists and dual GIP/GLP-1 agonists…
Approximately 10% of participants in controlled obesity trials fail to achieve even 5% total body weight loss on GLP-1…
A first-in-human mechanistic trial of vortex wave stimulation (VWS) in 14 healthy older adults demonstrated elevated…
The gut-eye axis emerges as a mechanistic bridge in dry eye disease (DED), with gut dysbiosis triggering systemic…
For the roughly 70–80% of advanced cancer patients who fail to respond to immune-checkpoint inhibitors (ICIs), the…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.